Renin-Angiotensin System Inhibitors and the COVID-19 Pandemic
| Errataetall: |
CommentOn: Am J Hypertens. 2023 Jun 15;36(7):404-410. - PMID 36960855 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
American journal of hypertension - 36(2023), 7 vom: 15. Juni, Seite 360-362 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Muchaili, Lweendo [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 16.06.2023 Date Revised 04.04.2024 published: Print CommentOn: Am J Hypertens. 2023 Jun 15;36(7):404-410. - PMID 36960855 Citation Status MEDLINE |
|---|
| doi: |
10.1093/ajh/hpad031 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355149540 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355149540 | ||
| 003 | DE-627 | ||
| 005 | 20240404234143.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ajh/hpad031 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1364.xml |
| 035 | |a (DE-627)NLM355149540 | ||
| 035 | |a (NLM)37010128 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Muchaili, Lweendo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Renin-Angiotensin System Inhibitors and the COVID-19 Pandemic |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.06.2023 | ||
| 500 | |a Date Revised 04.04.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Am J Hypertens. 2023 Jun 15;36(7):404-410. - PMID 36960855 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a 2 | |
| 650 | 4 | |a ACE2 | |
| 650 | 4 | |a COVID-19 pandemic | |
| 650 | 4 | |a SARS-COV | |
| 650 | 4 | |a blood pressure | |
| 650 | 4 | |a cardiovascular disease | |
| 650 | 4 | |a hypertension | |
| 650 | 4 | |a renin-angiotensin system inhibitors | |
| 650 | 7 | |a Peptidyl-Dipeptidase A |2 NLM | |
| 650 | 7 | |a EC 3.4.15.1 |2 NLM | |
| 650 | 7 | |a Antihypertensive Agents |2 NLM | |
| 700 | 1 | |a Mweene, Bislom C |e verfasserin |4 aut | |
| 700 | 1 | |a Masenga, Sepiso K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of hypertension |d 1988 |g 36(2023), 7 vom: 15. Juni, Seite 360-362 |w (DE-627)NLM012611670 |x 1941-7225 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2023 |g number:7 |g day:15 |g month:06 |g pages:360-362 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/ajh/hpad031 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 36 |j 2023 |e 7 |b 15 |c 06 |h 360-362 | ||